
Please try another search
Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was incorporated in 1965 and is headquartered in Taichung, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Jung-Chin Lin | 67 | 2019 | Director |
Mei-Hsing Tseng | - | 2017 | Director |
Wei-Kuang Chi | - | 2001 | Director |
Chien-Fu Chen | - | 2017 | Director |
Chung-Cheng Liu | - | 2012 | President, GM & Director |
Hsiao-Po Hsu | - | 2011 | Independent Director |
Chi-Heng Lin | - | 2008 | Director |
Chi-Hsien Chan | - | 2008 | CEO & Chairman |
Yung-Sheng Hsu | - | 2020 | Independent Director |
Mei-Hsiang He | - | 2017 | Independent Director |
Mei-Ling Hsiao | - | 2024 | Independent Director |
Chi-Lin Wei | 77 | - | Member of Supervisory Board |
Shyang Yang Feng | - | - | Member of Supervisory Board |
Ming Liang Guo | - | - | Member of Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review